Gerke MB, Marra A, Liu Y, Bedmutha A, et al. Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617. Cancer 2026;132:e70410.
PMID: 41989013